Jonathan Chang

1.8k total citations
21 papers, 605 citations indexed

About

Jonathan Chang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jonathan Chang has authored 21 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Jonathan Chang's work include Protease and Inhibitor Mechanisms (5 papers), Bone Metabolism and Diseases (4 papers) and Bone health and treatments (2 papers). Jonathan Chang is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Bone Metabolism and Diseases (4 papers) and Bone health and treatments (2 papers). Jonathan Chang collaborates with scholars based in United States, Switzerland and South Korea. Jonathan Chang's co-authors include Tove Tuntland, Jeannette S. Messer, Fanfei Lin, Candace M. Cham, Michael T. Lotze, Timothy R. Billiar, Xiaorong Zhu, Eugene B. Chang, Yunwei Wang and David L. Boone and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Jonathan Chang

21 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Chang United States 15 245 106 102 98 92 21 605
Timothy A. Subashi United States 9 349 1.4× 126 1.2× 96 0.9× 102 1.0× 75 0.8× 15 882
Ramya Krishna Vadlapatla United States 19 366 1.5× 88 0.8× 30 0.3× 93 0.9× 153 1.7× 29 878
Zhi Jie Li Hong Kong 17 485 2.0× 32 0.3× 103 1.0× 64 0.7× 159 1.7× 27 824
Haijun Yu China 17 335 1.4× 27 0.3× 87 0.9× 126 1.3× 272 3.0× 54 777
Zhanru Yu United Kingdom 11 385 1.6× 63 0.6× 297 2.9× 66 0.7× 56 0.6× 21 816
Shinsei Gasa Japan 21 754 3.1× 221 2.1× 189 1.9× 82 0.8× 86 0.9× 81 1.2k
Matthias Blumrich Germany 9 239 1.0× 38 0.4× 114 1.1× 39 0.4× 145 1.6× 12 496
Kwang‐Hoe Chung South Korea 20 433 1.8× 116 1.1× 66 0.6× 77 0.8× 87 0.9× 36 963
Guijin Zhai China 13 517 2.1× 48 0.5× 46 0.5× 147 1.5× 56 0.6× 33 696

Countries citing papers authored by Jonathan Chang

Since Specialization
Citations

This map shows the geographic impact of Jonathan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Chang more than expected).

Fields of papers citing papers by Jonathan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Chang. The network helps show where Jonathan Chang may publish in the future.

Co-authorship network of co-authors of Jonathan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Chang. A scholar is included among the top collaborators of Jonathan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Chang. Jonathan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Soojung, Jonathan Chang, Sung‐Min Kang, et al.. (2022). High-throughput formation and image-based analysis of basal-in mammary organoids in 384-well plates. Scientific Reports. 12(1). 317–317. 21 indexed citations
3.
Chang, Jonathan, et al.. (2022). Contracting scars from fibrin drops. Integrative Biology. 14(1). 1–12. 4 indexed citations
4.
Chang, Jonathan, et al.. (2021). Aqueous two-phase deposition and fibrinolysis of fibroblast-laden fibrin micro-scaffolds. Biofabrication. 13(3). 35013–35013. 8 indexed citations
5.
Chang, Jonathan, et al.. (2020). Integrated Biophysical Characterization of Fibrillar Collagen-Based Hydrogels. ACS Biomaterials Science & Engineering. 6(3). 1408–1417. 17 indexed citations
6.
Chang, Jonathan, Jocelyn R. Grunwell, Louise Hecker, et al.. (2019). Microphysiological systems modeling acute respiratory distress syndrome that capture mechanical force-induced injury-inflammation-repair. APL Bioengineering. 3(4). 41503–41503. 17 indexed citations
7.
Sizemore, Gina M., Vasudha Shukla, Steven T. Sizemore, et al.. (2017). Stromal PDGFR-α Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth. Neoplasia. 19(6). 496–508. 53 indexed citations
8.
Zhu, Xiaorong, Jeannette S. Messer, Yunwei Wang, et al.. (2015). Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. Journal of Clinical Investigation. 125(3). 1098–1110. 161 indexed citations
9.
Chang, Jonathan, Brandi N. Davis‐Dusenbery, Risa Kashima, et al.. (2013). Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress. The EMBO Journal. 32(24). 3192–3205. 31 indexed citations
10.
Li, Chun, Bo Liu, Jonathan Chang, et al.. (2012). A modern in vivo pharmacokinetic paradigm: combining snapshot, rapid and full PK approaches to optimize and expedite early drug discovery. Drug Discovery Today. 18(1-2). 71–78. 31 indexed citations
11.
Dubrovska, Anna, Jimmy Elliott, Weijun Shen, et al.. (2011). A Chemically Induced Vaccine Strategy for Prostate Cancer. ACS Chemical Biology. 6(11). 1223–1231. 40 indexed citations
12.
Deng, Xianming, A. S. Nagle, Tao Wu, et al.. (2010). Discovery of novel 1H-imidazol-2-yl-pyrimidine-4,6-diamines as potential antimalarials. Bioorganic & Medicinal Chemistry Letters. 20(14). 4027–4031. 18 indexed citations
13.
Wu, Tao, A. S. Nagle, Tomoyo Sakata, et al.. (2009). Cell-based optimization of novel benzamides as potential antimalarial leads. Bioorganic & Medicinal Chemistry Letters. 19(24). 6970–6974. 11 indexed citations
14.
Alper, Phil B., Thomas H. Marsilje, Daniel Mutnick, et al.. (2008). Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptor. Bioorganic & Medicinal Chemistry Letters. 18(19). 5255–5258. 24 indexed citations
15.
Chatterjee, Arnab K., Hong Liu, David C. Tully, et al.. (2007). Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S. Bioorganic & Medicinal Chemistry Letters. 17(10). 2899–2903. 11 indexed citations
16.
Liu, Bo, Jonathan Chang, W. Perry Gordon, et al.. (2007). Snapshot PK: a rapid rodent in vivo preclinical screening approach. Drug Discovery Today. 13(7-8). 360–367. 43 indexed citations
17.
Liu, Hong, Arnab K. Chatterjee, David C. Tully, et al.. (2006). Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl. Bioorganic & Medicinal Chemistry Letters. 16(6). 1486–1490. 14 indexed citations
18.
Tully, David C., Hong Liu, Arnab K. Chatterjee, et al.. (2006). Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(19). 5107–5111. 21 indexed citations
19.
Tully, David C., Hong Liu, Arnab K. Chatterjee, et al.. (2006). Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers. Bioorganic & Medicinal Chemistry Letters. 16(19). 5112–5117. 26 indexed citations
20.
Tully, David C., Hong Liu, Phil B. Alper, et al.. (2006). Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: Heterocyclic P3. Bioorganic & Medicinal Chemistry Letters. 16(7). 1975–1980. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy A. Subashi Breakdown of academic impact, for papers by Ramya Krishna Vadlapatla Breakdown of academic impact, for papers by Zhi Jie Li Breakdown of academic impact, for papers by Haijun Yu Breakdown of academic impact, for papers by Zhanru Yu Breakdown of academic impact, for papers by Shinsei Gasa Breakdown of academic impact, for papers by Matthias Blumrich Breakdown of academic impact, for papers by Kwang‐Hoe Chung Breakdown of academic impact, for papers by Guijin Zhai
Rankless by CCL
2026